[Anti-inflammatory properties of interleukin-10 in human Crohn's disease: much to learn, much to explore].
Stallmach
A
A
Innere Medizin II, Universitätskliniken des Saarlandes, Germany.
Schmidt
C
C
Marth
T
T
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy* / Q000517:prevention & control; D015316:Genetic Therapy; D006801:Humans; D016753:Interleukin-10 / Q000009:adverse effects / Q000235:genetics / Q000627:therapeutic use*; D051379:Mice; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012008:Recurrence
D000894:Anti-Inflammatory Agents, Non-Steroidal; D011994:Recombinant Proteins; D016753:Interleukin-10
Kontrainflammatorische Wirkungen von Interleukin-10 bei Patienten mit M. Crohn: viele Fragen, viele Möglichkeiten.